IPO de 223,3 M€ pour Abivax sur le Nasdaq

Gide a conseillé les banques (Morgan Stanley, Leerink Partners, LifeSci Capital et Bryan Garnier & Co) sur l’introduction d’Abivax sur le Nasdaq de 235,8 millions de…

This content is for members only.
Join Now
Already a member? Accedi

Author: Georgio Naffaa

…

This content is for members only.
Join Now
Already a member? Accedi